Search results
-
Betting on Gold Using a Futures-Based Gold ETF
Matos, PedroCase DARDEN-F-1690-EFinanceIn an environment of high macroeconomic uncertainty in the fall of 2012, Tom Michelson was looking at his next trading opportunity. Michelson wanted to build a position in gold with a trading horizon of around a year and was wondering how he should go about investing in gold. Gold futures-based exchange-traded funds (ETFs) seemed like a good alternative, but he needed to understand better how gold futures worked. He was aware that futures-based E...Starting at €8.20
-
2012 Fuel Hedging at JetBlue Airways
Matos, PedroCase DARDEN-F-1697-EFinanceIn early 2012, an equity analyst, was examining the jet fuel hedging strategy of JetBlue Airways for the coming year. Because airlines cross-hedged their jet fuel price risk using derivatives contracts on other oil products such as WTI and Brent crude oil, they were exposed to basis risk. In 2011, dislocations in the oil market led to a Brent-WTI premium wherein jet fuel started to move with Brent instead of WTI, as it traditionally did. Faced wi...Starting at €8.20
-
Hedge Fund Due Diligence at Leman Alternative Asset Management Company
Matos, PedroCase DARDEN-F-1698-EFinanceIn early January 2008, a senior VP with LAAMCO, a fund of hedge funds known for alternative investments, was conducting due diligence on an equity market-neutral hedge fund. The hedge fund used an option strategy known as a collar (also known as a bull spread or split-strike conversion). The track record of the hedge fund had been stellar. The fund’s performance had not only beaten that of the S&P 500 Index over the same period but had done so wi...Starting at €8.20
-
ProShares Hedge Replication ETF
Matos, Pedro; Demir, AnilCase DARDEN-F-1714-EFinanceAt the start of 2014, Joanne Hill was preparing to present at a conference focused on alternative investments for financial advisers. Exhibit 1 provides selected slides from the presentation. Hill wants to showcase how Hedge Replication ETF (HDG) provided an exposure to hedge funds at low fees, with full transparency and providing daily liquidity. But she had to overcome some resistance in the audience because most hedge fund strategies had under...Starting at €8.20
-
Hedge Fund Due Diligence at Leman Alternative Asset Management Company - Teaching Note
Matos, PedroTeaching Note DARDEN-F-1698TN-EFinanceTeaching note for product F-1698Starting at €0.00
-
The Sanofi-Aventis Acquisition of Genzyme: Contingent Value Rights - Teaching Note
Matos, PedroTeaching Note DARDEN-F-1715TN-EFinanceTeaching note for product F-1715Starting at €0.00
-
Principal-Protected Equity-Linked Note - Teaching Note
Matos, PedroTeaching Note DARDEN-F-1752TN-EFinanceTeaching note for product F-1752Starting at €0.00
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
The Indego Africa Project (Spanish Version)
McGinn, Kathleen L.; Gordon, RachelCase HBS-914S10Dos abogados jóvenes que se encuentran y comienzan a construir el Proyecto África Indego, una asociación de ONG con cooperativas de mujeres en Ruanda. Indego conecta las cooperativas en el mercado minorista internacional de productos artesanales hechos a mano, ayuda a las cooperativas construyen su capacidad de negocio, y desarrolla y ofrece formación en el aula en la vida y habilidades de negocio para los miembros de la cooperativa. En el moment...Starting at €8.20
-
Storming into the U.S. Market (Spanish version)
Bartlett, Christopher A.; Gordon, Rachel; Lafkas, JohnCase HBS-918S10StrategyThe RoboTech case describes the challenges facing the CEO of a small, Singapore-based industrial robotics company that decides to diversify away from its core industrial robot business by leveraging its expertise into the medical-devices industry. It launches an innovative product (a specialized surgical robot) in an unfamiliar market segment (spinal surgery) and decides to enter the unfamiliar, distant U.S. healthcare market, which is characteri...Starting at €8.20